To resume, agents targeting multiple receptor tyrosine kinases including FGFR showed in vitro sensitivity in rhabdoid tumor cells but activation of oncogenic intracellular signaling in epithelioid sarcoma. The gene discussed is NTRK1; the disease is rhabdoid tumor.